Anteris Technologies Global Corp. — Director's Dealing 2010

Feb 3, 2010

==> picture [595 x 64] intentionally omitted <==

Innovative BioMedical Devices

Level 11, 225 St Georges Terrace Telephone (08) 9262 6777 bioMD Limited ABN 35 088 221 078 Facsimile (08) 9322 3433 Perth, Western Australia 6000 PO Box 7209, Cloisters Square www.biomd.com.au Western Australia 6850

ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE

1 of 2 pages

4 February 2010

Company Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Dear Sir/Madam

Re: Appendix 3Y – Change in Director’s Interest Notice

The Directors of bioMD Ltd wish to advise of a change to the notifiable interests of a directors in accordance with Listing Rule 3.19A.1 and section 205G of the Corporations Act.

Please refer to the ‘Appendix 3Y’ attached for details of an off-market transfer between holdings for Mr Towner. His total holdings in bioMD remain the same.

Yours faithfully

==> picture [78 x 59] intentionally omitted <==

Caroline Bentley Company Secretary

==> picture [595 x 42] intentionally omitted <==

APPENDIX 3Y

CHANGE OF DIRECTOR’S INTEREST NOTICE

Name of Entity: bioMD Limited ABN: 35 055 221 078

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director:	Robert Towner
Date of last notice:	12 June 2009
PART 1– Change of director's relevant interests in securities
Direct or indirect interest:	Direct / Indirect
Nature of indirect interest:	Mr Towner is a director of two companies holding BOD
Date of change:	25 January 2010
**No. of securities held prior to change: **	Ordinary shares11,924,492 (indirect) and 5,687,500 (direct)
Class:	Listed ordinary shares (BOD)
Number acquired:	1,809,492 (indirect – Austin4 Pty Ltd)
Number disposed:	1,809,492 (indirect – Mandolin Pty Ltd)
Value/Consideration:	$Nil
No. of securities held after change:	Ordinary shares11,924,492 (indirect) and 5,687,500 (direct)
Nature of the change:	Off market transfer between indirect holdings
PART 2– Change of director’s interests in contracts
Details of contract:	None Applicable
Nature of interest:
Name of registered holder:
(if issued securities)
No. and class of securities to which interest relates:
Interest acquired:
Interest disposed:
Value/Consideration:
Interest after change: